Burke Sharon, Beckwith Anna Malia
Children's Specialized Hospital, New Brunswick, NJ, USA.
Children's Specialized Hospital, Mountainside, NJ, USA.
Glob Pediatr Health. 2017 Jul 25;4:2333794X17721128. doi: 10.1177/2333794X17721128. eCollection 2017.
. Compare developmental outcomes in infants treated with morphine versus methadone. . Retrospective chart review of newborns identified through use of ICD-9 code for neonatal abstinence syndrome (NAS). Thirty-six infants were evaluated-17 treated with methadone and 19 treated with morphine. Assessment was completed following treatment using the Bayley Scales of Infant and Toddler Development-Third Edition (Bayley-III). Scores in Cognitive, Language, and Motor domains were compared. . Comparison of scores between morphine- and methadone-treated groups revealed differences in mean Cognitive Composite (91.3 vs 83.0; = .03410) and mean Total Motor Composite Scores (96.3 vs 89.6; = .0149). . Newborns with NAS treated with morphine had significantly higher scores in Cognitive and Gross Motor domains compared to infants treated with methadone. Development screening should be pursued to determine if this difference persists throughout early childhood. Results may influence accepted treatment protocols for NAS.
. 比较接受吗啡与美沙酮治疗的婴儿的发育结果。. 对通过使用国际疾病分类第九版(ICD - 9)代码识别出的新生儿戒断综合征(NAS)进行回顾性病历审查。评估了36名婴儿,其中17名接受美沙酮治疗,19名接受吗啡治疗。治疗后使用贝利婴幼儿发展量表第三版(Bayley - III)完成评估。比较了认知、语言和运动领域的得分。. 吗啡治疗组和美沙酮治疗组得分比较显示,平均认知综合得分存在差异(91.3对83.0;P = 0.03410),平均总运动综合得分也存在差异(96.3对89.6;P = 0.0149)。. 与接受美沙酮治疗的婴儿相比,接受吗啡治疗的NAS新生儿在认知和大运动领域得分显著更高。应进行发育筛查以确定这种差异在幼儿期是否持续存在。结果可能会影响NAS公认的治疗方案。